Doximity ($DOCS) is presented as a financially strong healthcare network unfairly sold off on AI fears, with the author long shares and calls expecting recovery toward $65-80+.
DOCS — LONG The author argues Doximity's 80%+ US physician network, ~90% gross margins, 23% YoY revenue growth and profitable free cash flow are being mispriced after an AI-prompted selloff. The causal mechanism is that healthcare compliance, trust and distribution protect its pharma advertising and workflow revenue, while DoxGPT becomes an AI tailwind. The concrete catalyst is one good quarter or a major pharma partnership, potentially repricing the stock back to $65-80+, with the main stated risk being AI competition from OpenAI/Google/startups cracking healthcare compliance.
Feels like one good quarter or one big pharma partnership announcement and this rips back to $65-80+.
This Reddit post, published January 11, 2026, features u/IllustriousMind6714 discussing DOCS. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/IllustriousMind6714 · Tickers: DOCS